- Home
- MNTK vs ARCT Comparison
MNTK vs ARCT Comparison
Compare MNTK & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNTK
- ARCT
- Stock Information
- Founded
- MNTK 1980
- ARCT 2013
- Country
- MNTK United States
- ARCT United States
- Employees
- MNTK N/A
- ARCT N/A
- Industry
- MNTK Natural Gas Distribution
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- MNTK Utilities
- ARCT Health Care
- Exchange
- MNTK Nasdaq
- ARCT Nasdaq
- Market Cap
- MNTK 339.0M
- ARCT 298.3M
- IPO Year
- MNTK 2021
- ARCT N/A
- Fundamental
- Price
- MNTK $2.17
- ARCT $13.78
- Analyst Decision
- MNTK Hold
- ARCT Strong Buy
- Analyst Count
- MNTK 3
- ARCT 8
- Target Price
- MNTK $3.33
- ARCT $52.83
- AVG Volume (30 Days)
- MNTK 215.6K
- ARCT 484.0K
- Earning Date
- MNTK 08-07-2025
- ARCT 08-04-2025
- Dividend Yield
- MNTK N/A
- ARCT N/A
- EPS Growth
- MNTK N/A
- ARCT N/A
- EPS
- MNTK 0.05
- ARCT N/A
- Revenue
- MNTK $179,552,000.00
- ARCT $143,680,000.00
- Revenue This Year
- MNTK $2.49
- ARCT N/A
- Revenue Next Year
- MNTK $26.02
- ARCT $34.79
- P/E Ratio
- MNTK $41.66
- ARCT N/A
- Revenue Growth
- MNTK N/A
- ARCT 15.38
- 52 Week Low
- MNTK $1.68
- ARCT $8.04
- 52 Week High
- MNTK $6.13
- ARCT $25.88
- Technical
- Relative Strength Index (RSI)
- MNTK 47.04
- ARCT 54.34
- Support Level
- MNTK $2.22
- ARCT $13.10
- Resistance Level
- MNTK $2.78
- ARCT $15.20
- Average True Range (ATR)
- MNTK 0.19
- ARCT 1.02
- MACD
- MNTK -0.02
- ARCT 0.07
- Stochastic Oscillator
- MNTK 27.38
- ARCT 55.21
About MNTK Montauk Renewables Inc.
Montauk Renewables Inc is a renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments namely Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.